- Home
- SLI vs PRLD Comparison
SLI vs PRLD Comparison
Compare SLI & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLI | PRLD |
|---|---|---|
| Founded | 1998 | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.3M | 260.2M |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SLI | PRLD |
|---|---|---|
| Price | $1.45 | $3.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $4.49 | ★ $9.20 |
| AVG Volume (30 Days) | ★ 2.1M | 428.3K |
| Earning Date | 08-10-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,140,000.00 |
| Revenue This Year | N/A | $258.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 73.43 |
| 52 Week Low | $1.32 | $1.17 |
| 52 Week High | $6.00 | $6.83 |
Technical Indicators
Market Signals| Indicator | SLI | PRLD |
|---|---|---|
| Relative Strength Index (RSI) | 28.27 | 41.56 |
| Support Level | $1.32 | $3.55 |
| Resistance Level | $2.25 | $4.07 |
| Average True Range (ATR) | 0.08 | 0.25 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 30.49 | 51.76 |
Price Performance
Historical ComparisonAbout SLI Standard Lithium Ltd.
Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company's flagship projects are located in the Smackover Formation, a world-class lithium brine asset, focused in Arkansas and Texas. It is also Standard Lithium is advancing the South West Arkansas project, a greenfield project located in southern Arkansas, and strengthening lithium brine prospects in East Texas. Its other project comprises the Lanxess Property Project; and California Properties. The technologies used for the projects are : Direct Lithium Extraction; Demonstration Plant; SiFT; Lithium Sulfide; and Aqualung.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.